Abstract
The structure of human HGPRT bound to the transition-state analog immucillinGP and Mg2+-pyrophosphate has been determined to 2.0 A resolution. ImmucillinGP was designed as a stable analog with the stereoelectronic features of the transition state. Bound inhibitor at the catalytic site indicates that the oxocarbenium ion of the transition state is stabilized by neighboring-group participation from MgPPi and O5'. A short hydrogen bond forms between Asp 137 and the purine ring analog. Two Mg2+ ions sandwich the pyrophosphate and contact both hydroxyls of the ribosyl analog. The transition-state analog is shielded from bulk solvent by a catalytic loop that moves approximately 25 A to cover the active site and becomes an ordered antiparallel beta-sheet.
MeSH terms
-
Binding Sites
-
Catalytic Domain
-
Crystallization
-
Crystallography, X-Ray
-
Diphosphates / chemistry*
-
Diphosphates / metabolism
-
Electrons
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / metabolism
-
Humans
-
Hydrogen Bonding
-
Hypoxanthine Phosphoribosyltransferase / antagonists & inhibitors
-
Hypoxanthine Phosphoribosyltransferase / chemistry*
-
Hypoxanthine Phosphoribosyltransferase / metabolism
-
Ions
-
Magnesium / metabolism
-
Magnesium Compounds / chemistry*
-
Magnesium Compounds / metabolism
-
Models, Molecular
-
Molecular Sequence Data
-
Nitrogen / metabolism
-
Oxygen / metabolism
-
Phosphates / metabolism
-
Protein Binding
-
Protein Structure, Secondary
-
Pyrimidinones / chemistry*
-
Pyrimidinones / metabolism
-
Pyrroles / chemistry*
-
Pyrroles / metabolism
-
Solvents
Substances
-
Diphosphates
-
Enzyme Inhibitors
-
Ions
-
Magnesium Compounds
-
Phosphates
-
Pyrimidinones
-
Pyrroles
-
Solvents
-
immucillin G
-
magnesium pyrophosphate
-
Hypoxanthine Phosphoribosyltransferase
-
Magnesium
-
Nitrogen
-
Oxygen